1. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison
   Sijia Shen et al, 2016, Sci Rep CrossRef
2. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
   Wataru Okajima et al, 2017, WJG CrossRef
3. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma
   Sirio Fiorino et al, 2016, WJG CrossRef
4. MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection
   Er-Lei Zhang et al, 2017 CrossRef
5. Diagnostic value of strand-specific miRNA-101-3p and miRNA-101-5p for hepatocellular carcinoma and a bioinformatic analysis of their possible mechanism of action
   Xia Yang et al, 2017, FEBS Open Bio CrossRef
6. MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.
   Sumadi Anwar et al, 2015, J Clin Med CrossRef
7. Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers
   Tsutomu Kawaguchi et al, 2016, IJMS CrossRef
8. MiR-106b regulates the apoptosis and tumorigenesis of hepatocellular carcinoma via targeting Zinc finger and BTB domain-containing protein 7A (Zbtb7a)
   Xiao Liang et al, 2018, J Biochem Mol Toxicol CrossRef
9. miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
   Chang-Hai Liu et al, 2018, Journal of Hepatology CrossRef
10. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review
    Tatsuo Kanda et al, 2019, IJMS CrossRef
11. null
    Jun Zhao et al, 2015 CrossRef
12. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
    Yun Xie et al, 2014, Cancer Biology & Therapy CrossRef
13. miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7.
    Ying Ma et al, 2014, Tumour Biol. CrossRef
14. Circulating miRNAs: Roles in cancer diagnosis, prognosis and therapy
    Guofeng Cheng, 2015, Advanced Drug Delivery Reviews CrossRef
15. Circulating microRNAs in response to exercise
    T. Xu et al, 2015, Scand J Med Sci Sports CrossRef
16. Significant biomarkers for the management of hepatocellular carcinoma
    Yasuteru Kondo et al, 2015, Clin J Gastroenterol CrossRef
17. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis
    G. Li et al, 2015, Clin Transl Oncol CrossRef
18. Applications of molecular communications to medicine: A survey
    L. Felicetti et al, 2016, Nano Communication Networks CrossRef
19. The role of microRNAs in enteroviral infections
    Jing Wu et al, 2015, The Brazilian Journal of Infectious Diseases CrossRef
20. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma
    Fabrizio Bronte et al, 2016, Critical Reviews in Oncology/Hematology CrossRef
21. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma
    Chunbo Zhuang et al, 2016, Clinics and Research in Hepatology and Gastroenterology CrossRef
22. Hepatocellular carcinoma diagnosis: Circulating microRNAs emerge as robust biomarkers
    Angélique Gougelet et al, 2016, Clinics and Research in Hepatology and Gastroenterology CrossRef
23. Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.
    Jian Zhou et al, 2016, J Gastrointest Cancer CrossRef
24. A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers
    David E. Amacher, 2016, Biomarkers CrossRef
25. Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Human Infectious Diseases
    Parmila Verma et al, 2016, Front. Microbiol. CrossRef
26. null
    Luca Felicetti et al, 2017 CrossRef
27. The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis
    null Sartorius et al, 2019, Cells CrossRef
28. Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms
    Sukanya Roy et al, 2019, Front. Med. CrossRef
29. Liquid biopsy in chronic liver disease
    Hugo A. Barrera-Saldaña et al, 2020, Annals of Hepatology CrossRef
30. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7
    Jun-Tang Li et al, 2015, Oncotarget CrossRef
31. The Multiple Roles of Hepatitis B Virus X Protein (HBx) Dysregulated MicroRNA in Hepatitis B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) and Immune Pathways
    Kurt Sartorius et al, 2020, Viruses CrossRef
32. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets
    Jinghang Xu et al, 2020, Front. Oncol. CrossRef
33. MiR-378a-3p as a putative biomarker for hepatocellular carcinoma diagnosis and prognosis: Computational screening with experimental validation.
    Fuliang Qian et al, 2021, Clin Transl Med CrossRef
34. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation
    Kurt Sartorius et al, 2021, Front. Immunol. CrossRef
35. Erythrocyte miRNA regulators and malarial pathophysiology
    Sowmya R. Prabhu et al, 2021, Infection, Genetics and Evolution CrossRef
36. Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
    Zhu-qing Zhang et al, 2014, Diagn Pathol CrossRef
37. CircRNA-PI4KB Induces Hepatic Lipid Deposition in Non-Alcoholic Fatty Liver Disease by Transporting miRNA-122 to Extra-Hepatocytes
    Chang-Hai Liu et al, 2023, IJMS CrossRef
38. null
    Luca Felicetti et al, 2014 CrossRef